CHELSEY ZIMMERMAN: Open Payments
NPI 1619333440 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 16 payments from 10 companies in 2025. Trend: 2023 $482 · 2024 $805 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| MILLICENT US INC | 3 | $55 |
| Organon LLC | 3 | $52 |
| PFIZER INC. | 3 | $49 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Sage Therapeutics, LLC | 1 | $24 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $19 |
| Amgen Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: INTRAROSA, NEXPLANON, ABRYSVO, Qelbree, ZURZUVAE, JOURNAVX, EVENITY, Cologuard Collection Kit.
Industry payments across PA — which companies pay providers there.
